⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12071335 | 0.71 | LYN (0.55) | — | |
| SCHEMBL7443218 | 0.70 | — | — | |
| SCHEMBL4422067 | 0.70 | — | — | |
| SCHEMBL8616381 | 0.70 | — | — | |
| SCHEMBL309070 | 0.70 | — | — | |
| SCHEMBL312460 | 0.70 | — | — | |
| SCHEMBL6526251 | 0.70 | — | — | |
| SCHEMBL1093395 | 0.70 | LYN (0.33) | — | |
| SCHEMBL2222457 | 0.69 | NNMT (0.44) | — | |
| Hydrochloric Acid SCHEMBL1938631 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688143-A1 | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LIVER DISEASE | ProQR Therapeutics II B.V. (NL) | 2026-02-11 | — | — | EP | claimed |
| US-20260027237-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES FOR ADAR-MEDIATED RNA EDITING | PROQR THERAPEUTICS II B.V. (NL) | 2026-01-29 | — | — | US | claimed |
| EP-3433283-B1 | GELLAN GUM HYDROGELS, PREPARATION, METHODS AND USES THEREOF | STEMMATTERS BIOTECNOLOGIA E MEDICINA REGENERATIVA S A (PT) | 2025-09-10 | — | — | EP | claimed |
| EP-4605531-A1 | HETERODUPLEX RNA EDITING OLIGONUCLEOTIDE COMPLEXES | ProQR Therapeutics II B.V. (NL) | 2025-08-27 | — | — | EP | claimed |
| EP-4555085-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES FOR ADAR-MEDIATED RNA EDITING | ProQR Therapeutics II B.V. (NL) | 2025-05-21 | — | — | EP | claimed |
| WO-2025061911-A1 | METHODS OF PRODUCING NUCLEOTIDE TRIPHOSPHATES (NTPS) | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2025-03-27 | — | — | WO | claimed |
| WO-2024200472-A1 | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LIVER DISEASE | PROQR THERAPEUTICS II B.V. (NL) | 2024-10-03 | — | — | WO | claimed |
| WO-2024013360-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES FOR ADAR-MEDIATED RNA EDITING | PROQR THERAPEUTICS II B.V. (NL) | 2024-01-18 | — | — | WO | claimed |
| US-11352447-B2 | Gellan gum hydrogels, preparation, methods and uses thereof | Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. (PT) | 2022-06-07 | — | — | US | claimed |
| CN-114173575-A | Method for processing broad bean composition | 绿色乳制品瑞典控股股份公司 | 2022-03-11 | — | — | CN | claimed |
| CN-109153734-A | Gellan gum hydrogel, preparation method and application thereof | 斯泰玛特斯，生物技术药物改造有限公司 | 2019-01-04 | — | — | CN | claimed |
| EP-4728071-A1 | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE | ProQR Therapeutics II B.V. (NL) | 2026-04-22 | — | — | EP | disclosed |
| EP-4688143-A1 | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LIVER DISEASE | ProQR Therapeutics II B.V. (NL) | 2026-02-11 | — | — | EP | disclosed |
| EP-4689107-A1 | CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES FOR USE IN RNA EDITING | ProQR Therapeutics II B.V. (NL) | 2026-02-11 | — | — | EP | disclosed |
| EP-4689110-A1 | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | ProQR Therapeutics II B.V. (NL) | 2026-02-11 | — | — | EP | disclosed |
| US-20060116356-A1 | Phosphonate analogs of HIV integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2006-06-01 | — | — | US | disclosed |
| US-20050282839-A1 | Pyrimidyl phosphonate antiviral compounds and methods of use | GILEAD SCIENCES, INC. | 2005-12-22 | — | — | US | disclosed |
| WO-2005117904-A2 | PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| CN-1678261-A | Vaginal health product | KIMBERLY CLARK CO (US) | 2005-10-05 | — | — | CN | disclosed |
| WO-2005070901-A2 | PYRIMIDYL PHOSPHONATE ANTIVIRAL COMPOUNDS AND METHODS OF USE | GILEAD SCIENCES, INC. (US) | 2005-08-04 | — | — | WO | disclosed |